Associations of Reactive Thrombocytosis With Clinical Characteristics in Pediatric Diseases  by Wang, Jinn-Li et al.
Pediatrics and Neonatology (2011) 52, 261e266ava i lab le at www.sc iencedi rec t .com
journa l homepage: ht tp : / /www.pedia t r -neonato l . comORIGINAL ARTICLE
Associations of Reactive Thrombocytosis With
Clinical Characteristics in Pediatric DiseasesJinn-Li Wang a,b,*, Liang-Ti Huang a,b, Kuan-Hsun Wu a, Hui-Wen Lin c,d,
Man-Yan Ho a, Hsingjin Eugene Liu b,d,e,f,**aDepartment of Pediatrics, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan
bGraduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
cBiostatistics and Research Consultation Center, Taipei Medical University, Taiwan
dDepartment of Mathematics, Soochow University, Taipei, Taiwan
eDepartment of Internal Medicine, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan
fDepartment of Laboratory Medicine, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan
Received Jun 8, 2010; received in revised form Oct 4, 2010; accepted Oct 22, 2010Key Words
age;
hemoglobin;
pediatric;
reactive
thromobocytosis;
white blood cell count* Corresponding author. Department
Taipei, Taiwan.
** Corresponding author. Graduate In
E-mail address: jlwang@w.tmu.ed
1875-9572/$36 Copyright ª 2011, Taiw
doi:10.1016/j.pedneo.2011.06.004Background: Reactive thrombocytosis (RT) in pediatric patients is common, but usually
without symptoms. The incidence of RT is different depending on age. Mostly, we reason that
RT is a phenomenon, nevertheless the diagnostic value of RT is little known. Therefore, the
aim of this study was to determine the association of RT and clinical or laboratory character-
istics in pediatric diseases.
Methods: We retrospectively analyzed the medical records of pediatric patients hospitalized
at Wan Fang hospital from January 2002 to July 2009. Thrombocytosis was defined as a platelet
count more than 500  109/L. There were 822 patients enrolled to this study. The clinical
parameters, including age, gender, disease type, and hospitalization days, were investigated.
The association between RT and clinical manifestations and the relationship of leukocytes,
hemoglobin, C-reactive protein, and platelet counts were analyzed.
Results: The overall incidence of RT in hospitalized pediatric patients was 6.3%. Infants had
a significantly higher incidence (11.3%, p < 0.001). Mild RT was found in most patients
(83.6%). Infections (75.4%) were the most common cause, followed by perinatal diseases
(11.1%). The relationship of RT and age revealed a positive correlation (pZ 0.045, rZ 0.70
after adjustment). The degree of RT was an independent factor for hospitalization days
(p< 0.001, rZ 0.126 after adjustment). There was a positive correlation between white bloodof Pediatrics, Taipei Medical University-Wan Fang Hospital, No. 111, Hsing-Long Road, Section 3,
stitute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
u.tw (J.-L. Wang).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
262 J.-L. Wang et alcell count and platelets (pZ 0.002, rZ 0.017); on the contrary, the relationship between
hemoglobin level and platelets was an inverse correlation (p< 0.001, rZ0.193).
Conclusions: In children, the degree of RT was associated with age, and patients had signifi-
cantly longer hospitalization days in proportion to the increase in platelet count. Laboratory
association revealed that the degree of RT was positively correlated to white cell count and
negatively correlated to hemoglobin level. Therefore, the degree of RT might be a predictive
factor with regard to hospitalization days in pediatric diseases.
Copyright ª 2011, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.0
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Figure 1 The incidence of childhood reactive thrombocytosis
stratified by age (Chi-square test, p< 0.001).1. Introduction
Thrombocytosis is often defined as platelet count more
than 500 109/L.1 Secondary or reactive thrombocytosis
(RT), in contrast to primary thrombocytosis, is common,
often seen in pediatric hospitalized patients. The esti-
mated incidence of RT among hospitalized children is
6e15%, and it varies with age, with the highest rate in
infants, then becoming more infrequent in older children.2
This may be because of high thrombopoietin levels in the
neonatal period, which fall gradually with age.3
The most common causes of RT are infections, chronic
inflammation, anemia, tissue damage, prematurity, and
neoplasia.1,4 In general, childhood RT is a benign condition
and antithrombotic prophylaxis treatment is not necessary.5
The relationship between RT and pediatric diseases,
however, is seldom reported. In children, RT might be
related to the severity of lower respiratory tract infections,6
whereas another study suggests that RT has no relationship
to the degree of inflammation with community-acquired
pneumonia.7 Therefore, the role of RT still needs to be
determined in pediatric diseases.
To understand the clinical relevance of RT in pediatric
diseases, we retrospectively reviewed the medical records
of children with RT in a single institute during an 8-year
period. The aim of our present study was to analyze the
relationship between RT and specific clinical or laboratory
parameters, further elucidating the diagnostic value of RT
in pediatric diseases.
2. Materials and Methods
2.1. Patient inclusion and methods
We reviewed the medical records of patients between birth
and 18 years old admitted to Wan Fang Hospital from
January 2002 to July 2009. The laboratory data of complete
blood count and C-reactive protein (CRP) was obtained in
all patients. White blood cell (WBC) count, hemoglobin
(Hb), and platelets were determined using ethyl-
enediaminetetraacetic acid-anticoagulated whole blood on
an automatic cell counter (Beckman Coulter LH750; Full-
erton,CA,USA) andmeasurementofCRPwasperformedbyan
immunoturbidimetric method (Beckman LXi725, Krefeld,
Germany). The criteria for inclusion of RTwere patients with
platelet count more than 500 109/L, recovering to the
normal range after admission. We excluded patients with
primary thrombocytosis. RT patients were divided into fourgroups, Grade I (mild, 500 109/L< platelets 700 109/L),
Grade II (moderate, 700 109/L < platelets  900 109/L),
Grade III (severe, 900 109/L < platelets  1000 109/L),
and Grade IV (extreme, platelets > 1000 109/L).1 The
association between clinical parameters, including age,
gender, disease type, hospitalization days, and the degree of
RT was analyzed and the relationship of WBC count, Hb, and
CRP levels atpeakplateletcount andRTwas investigated.The
studywas approvedby the institutional reviewboard of Taipei
Medical University.
2.2. Statistical analysis
We used SPSS 16.0 for Windows (SPSS Inc., Chicago, IL, USA)
for statistical analysis. Analysis of variance and Chi-square
tests were used to analyze the association between age,
gender, disease type, hospitalization days, and the degree
of RT. Linear regression analyses were used to investigate
the relationship of platelet count and age as well as
hospitalization days, and further, we evaluated the corre-
lation between platelet count and laboratory parameters.
The correlation coefficient (r) was used to assess the
intervariable reliability. A p value less than 0.05 was
regarded as statistically significant.
3. Results
During the period, there were 14,050 pediatric hospitalized
patients excluding healthy newborns, and 887 patients
were found to have RT on admission or during hospitaliza-
tion. Only the highest platelet count was used for analysis
when a patient had more than two hospitalizations. As
a result, only 822 patients were included in this study. The
Table 1 Associations between age, gender, disease types, hospitalization days, and degree of reactive thrombocytosis.
Parameters Total I (nZ 687) II (nZ 105) III (nZ 16) IV (nZ 14) p
Age (mean SD)a 20.1 32.45 18.88 30.98 24.20 39.92 21.50 22.23 47.50 53.16 0.005
Genderb
Male, n (%) 474 (57.7) 392 (57.1) 60 (57.1) 12 (75.0) 10 (71.4) 0.366
Female, n (%) 348 (42.3) 295 (42.9) 45 (42.9) 4 (25) 4 (28.6)
Disease typeb
Infections, n (%) 620 (75.4) 512 (74.5) 83 (79.0) 14 (87.5) 11 (78.6) 0.562
Perinatal, n (%) 91 (11.1) 82 (11.9) 9 (8.6) 0 (0) 0 (0)
Tissue damage, n (%) 51 (6.2) 42 (6.1) 8 (7.6) 0 (0) 1 (7.1)
Neurologic, n (%) 20 (2.4) 16 (2.3) 3 (2.9) 1 (6.2) 0 (0)
Oncology/hematology, n (%) 15 (1.8) 13 (1.9) 1 (1.0) 0 (0) 1 (7.1)
Miscellaneous, n (%) 25 (3.2) 22 (3.2) 1 (1.0) 1 (6.2) 1 (7.1)
Hospitalization days (mean SD)a 7.94 12.49 7.14 11.56 12.31 17.64 10.50 6.46 11.43 7.93 0.001
Data are presented as n (%) or mean SD.
a One way ANOVA.
b Chi-square test.
ANOVAZ analysis of variance; SDZ standard deviation.
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patients in this study was 6.3%. We investigated the inci-
dence according to different age and found that RT was
more significantly likely seen in patients younger than 1
year (11.3%, p< 0.001, Figure 1); the incidence decreased
with age. In particular, infants younger than 3 months old
accounted for 34.9% of all RT patients.
In RT patients, there was a male preponderance, with
a ratio of 1.36:1, and the mean age was 20.1 32.45
months old. The percentages of Grade I, II, III, and IV RT
were 83.6%, 12.9%, 1.9%, and 1.6%, respectively. The age in
extreme RT was significantly older (pZ 0.005; Grade I vs.Table 2 Multiple comparisons between age and hospital-
ization days and the degree of reactive thrombocytosis.
Degree of RT Age Hospitalization days
p p
I II 0.48 0.001
III 0.991 0.165
IV 0.013 0.650
II III 0.992 0.960
IV 0.093 0.996
III IV 0.184 0.998
Post hoc Scheffe procedure.
RTZ reactive thrombocytosis.
Table 3 Regression analyses of age and hospitalization days re
Regression analyses Univariate
Correlation coefficient (r)
RT vs. hospitalization days 0.128
Age vs. RT 0.069
a After adjustment for age, gender, and disease type.
b After adjustment for gender and disease type.
RTZ reactive thrombocytosis.Grade IV, pZ 0.013 post hoc, Tables 1 and 2). Such
tendency was also found after linear regression analyses
(pZ 0.045, rZ 0.70 after adjustment, Table 3). Impor-
tantly, we found that the degree of RT was significantly
associated with hospitalization days (pZ 0.001; Grade I
vs. Grade II, pZ 0.001 post hoc, Tables 1 and 2) and not
related to gender or disease type. After multivariate
regression analyses, the platelet count still had a signifi-
cantly positive correlation to hospitalization days
(p< 0.001, rZ 0.126 after adjustment, Table 3).
With regard to the etiologies of RT, we divided the
disease types into six groups. We found that the most
common cause was infections (75.4%), followed by peri-
natal diseases (11.1%). Table 4 shows the distribution of
etiologies. No thrombotic or hemorrhagic complications
were seen in any patients, even in extreme RT.
We further evaluated the relationship between platelet
count and WBC count, Hb, and CRP levels. The degree of RT
was positively correlated with the elevation of WBC counts
(pZ 0.002, rZ 0.017). In contrast, the degree of RT was
inversely correlated with Hb level (p< 0.001, rZ0.193),
but there was no correlation to CRP level (pZ 0.239,
rZ 0.046), as shown in Figure 2.
4. Discussion
To our knowledge, few investigations on a large scale have
addressed the clinical significance of RT in pediatriclated to reactive thrombocytosis.
Multivariate
p Correlation coefficient (r) p
<0.001 0.126 <0.001a
0.049 0.070 0.045b
Table 4 Etiologies of childhood reactive thrombocytosis.
Causes Patients, n (%)
Infections (n Z 620)
Respiratory 391 (63.0)
Gastrointestinal 118 (19.0)
Urinary tract 63 (10.1)
Cellulitis 25 (4.0)
Lymphadenitis 10 (1.6)
Meningitis 8 (1.3)
Septic arthritis 5 (0.08)
Perinatal diseases (n Z 91)
Neonatal jaundice 48 (52.7)
Neonatal infection/omphalitis 14 (15.4)
Prematurity 13 (14.3)
Transient tachypnea of newborn 8 (8.8)
Congenital anomaly 8 (8.8)
Tissue damage (n Z 51)
Inguinal hernia/undescended testis 31 (60.7)
Appendicitis/ileus/intestinal/perforation 13 (25.5)
Bone fracture 3 (5.8)
Head injury 2 (3.9)
Burn injury 2 (3.9)
Neurologic diseases (n Z 20)
Epilepsy/seizure 11 (55.0)
Neuromuscular/cerebral palsy 7 (35.0)
Near-drowning/hypoxia 2 (10.0)
Oncology/hematology (n Z 15)
Malignancy 9 (60.0)
Anemia 6 (40.0)
Miscellaneous (n Z 25)
Allergic urticaria 7 (28.0)
Kawasaki disease 5 (20.0)
Dental caries-induced gingivitis 5 (20.0)
Others 8 (32.0)
Total 822
264 J.-L. Wang et alpatients. In our retrospective study, the overall incidence
of RT was 6.3%, with infants showing a significantly higher
incidence (11.3%, p< 0.001), especially in patients less
than 3 months old. In most cases, the platelet count was
only slightly elevated (mild), found in reported studies with
a similar distribution.1,8,9 RT occurred in a variety of clinical
conditions, and infections (75.4%) were the most common
cause. However, we found that there was a significant
correlation between age and the degree of RT (pZ 0.045,
rZ 0.70 after adjustment), and older children being more
likely to have extreme RT. Furthermore, the degree of RT
was an independent factor with respect to the hospitali-
zation days (p< 0.001, rZ 0.126 after adjustment),
although patients with Grade III and IV RT did not have
longer hospitalization. The small numbers of the two groups
might have caused the difference. Intriguingly, we discov-
ered that there was a significantly positive correlation to
WBC count (pZ 0.002, rZ 0.107) and a significantly
inverse correlation to Hb level (p< 0.001, rZ0.193)
related to the degree of RT.The age distribution was exceptionally high in
neonates, infants, and young children,2 and similar find-
ings were made in our study. The high platelet count is
believed to have been caused by the bone marrow
precursors responding to stress in young children.3,10
However, the relationship of the degree of RT and age is
seldom reported. According to a study by Chan et al,10
marked RT (>900 109/L) was commonly seen in young
children (median age, 9 months). But, we discovered that
the older patients had a tendency to have a higher
elevation in platelet count. Different underlying diseases,
which we encountered in our study, caused the degree of
inflammation, and the low percentage in severe and
extreme RT patients (only 3.5%) perhaps allowed the
differences.
Recently, research has suggested that platelets play an
active role in microbial host defenses and are an integral
part of inflammation through adaptive and innate immune
response, in addition to their function in hemostasis.11e13
The elevation of platelet count could reflect the degree
of inflammation, and previous studies have shown that the
platelet count could be a useful clinical marker in children
with severe lower respiratory tract infection. In cancer
patients, however, thrombocytosis was associated with
poor prognosis.6,14 Interleukin-6, which plays a prominent
role in response to inflammation, may be a key mediator
of the increased synthesis of thrombopoietin and conse-
quent RT.15,16 In pediatric patients, hospitalization days
might be related to the degree of inflammation, there-
fore, the degree of RT could be used to predict the length
of hospitalization in patients with pediatric diseases.
Clinical complications do not occur in patients with RT,
regardless of the degree of the platelet count elevation,
unless the underlying systemic disorders predispose
patients to them.17 In contrast, bleeding and thrombotic
complications are the major clinical complications in
patients with primary thrombocytosis. Qualitative platelet
abnormalities and endothelial dysfunction contribute to
hemostatic complications.17 Therefore, antithrombotic
treatment for prophylaxis needs to be used in primary
thrombocytosis and not in RT.
Regarding the mechanisms of leukocytosis and the
decrease of Hb levels in childhood RT, they seem unclear.
During inflammation, platelets contribute to chemotaxis
interactions by stimulating adhered leukocytes, regulating
chemokine synthesis,11,12 and increasing inflammatory
cytokines, such as interleukin-6, and the granulocyte-
colony stimulating factor, which stimulates the production
of granulocytes.18,19 In addition, anemia is caused by
a response to inflammation because of the shortening of
the lifespan of red blood cells, impaired erythropoietin
production, and iron metabolism by inflammatory cyto-
kines.20,21 Based on the above theories, we are able to
explain the phenomenon of RT accompanied by increased
WBC count and decreased Hb level.
In conclusion, we have identified the incidence of
childhood RT during different ages and its associations with
clinical characteristics. The degree of RTwas related to age
and reflected the degree of inflammation as a predictor of
hospitalization days in pediatric diseases. Further research
considering the effects of inflammatory cytokine on plate-
lets is needed to prove our opinion.
Figure 2 The relationship between platelet counts in reactive thrombocytosis and (A) WBCs, (B) Hb, or (C) CRP. CRPZ C-reactive
protein; HbZ hemoglobin; WBCZwhite blood count.
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